Pliant Therapeutics (PLRX) Current Assets (2019 - 2026)

Pliant Therapeutics (PLRX) has 8 years of Current Assets data on file, last reported at $174.9 million in Q1 2026.

• Current Assets for Q1 2026 came in at $174.9 million, down 43.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $174.9 million (down 43.79% YoY), and the FY2025 annual result was $196.4 million, down 45.77% from the prior year.
• Current Assets slipped to $174.9 million in Q1 2026 per PLRX's latest filing, from $196.4 million in the prior quarter.
• Over five years, Current Assets peaked at $588.2 million in Q1 2023 and troughed at $173.5 million in Q2 2022.
• A 5-year average of $362.6 million and a median of $362.3 million in 2024 frame the typical range for Current Assets.
• The sharpest annual moves came in 2023 and 2025: Current Assets soared 226.0% in 2023, then sank 45.77% in 2025.
• A 5-year view of Current Assets shows it stood at $340.3 million in 2022, then jumped by 48.54% to $505.5 million in 2023, then slipped by 28.34% to $362.3 million in 2024, then slumped by 45.77% to $196.4 million in 2025, then dropped by 10.95% to $174.9 million in 2026.
• Business Quant data shows PLRX's Current Assets at $174.9 million in Q1 2026, $196.4 million in Q4 2025, and $245.6 million in Q3 2025.